StockData
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc. (ANRO) stock

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$29.54−1.08 (-3.53%)

Close on Nov 13, 2026Market cap $1.16BP/E –Yield –

Alto Neuroscience statistics

65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 15, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$1.16B
$272.32M
Enterprise Value
$853.35M
$146.23M
PB Ratio
3.91
2.00
P/TBV Ratio
3.91
2.22

Share statisticsIndustry

Shares Change (YoY)
44.8%
10.8%
Shares Change (QoQ)
13.9%
0.50%
Float
37M
49M
Shares Held by Insiders
5.59%
11.7%
Shares Held by Institutions
75.1%
56.4%

Short sellingIndustry

Short Interest
6M
–
Short Interest Change
9.19%
-0.80%
Short % of Float
15.3%
9.01%
Short % of Shares Outstanding
14.5%
6.30%
Days to Cover
10.51
5.15

Stock price statisticsIndustry

52-Week High
$37.48
–
52-Week Low
$10.80
–
20-Day Moving Average
$24.62
–
50-Day Moving Average
$26.36
–
200-Day Moving Average
$24.74
–
Average True Range (14)
$2.01
–
Price Change (1 Week)
17.4%
-1.15%
Price Change (1 Month)
30.6%
-4.87%
Price Change (3 Months)
-12.1%
-21.0%
Price Change (6 Months)
28.5%
-20.6%
Price Change (YTD)
66.0%
-23.6%
Price Change (1 Year)
108.0%
-22.4%
Average Volume (10 Days)
691,859
–
Average Volume (20 Days)
610,807
–
Average Volume (90 Days)
576,079
–
Relative Volume
1.06
0.70
Relative Strength Index (14)
63.6
43.4
Volatility (1 Year)
77.4%
80.1%
Beta (5 Years)
1.86
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-46.6%
-49.9%
Return on Assets (ROA)
-40.2%
-40.6%
Return on Capital Employed (ROCE)
-32.6%
-37.9%

Financial positionIndustry

Current Ratio
18.12
3.30
Quick Ratio
17.90
2.39
Debt / Equity
0.05
0.49
Interest Coverage
-48.48
-6.35

EfficiencyIndustry

Profits Per Employee
-$1.40M
-$689.41K
Employee Count
68
74
WACC
14.4%
10.2%

Income statement (TTM)Industry

Operating Income
-$100.55M
-$21.37M
Net Income
-$95.18M
-$22.35M
EBITDA
-$100.55M
-$17.21M
EPS (Diluted)
-$2.46
-$0.76

Balance sheetIndustry

Total Debt
$13.48M
$116.91M
Net Cash (Debt)
$305.86M
$17.76M
Net Cash Per Share
$7.79
$0.80
Equity (Book Value)
$296.53M
$53.89M
Book Value Per Share
$7.56
$1.50
Tangible Book Value
$296.53M
$27.13M
Working Capital
$305.36M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$79.12M
-$12.38M
Capital Expenditures
-$556.00K
-$1.00M
Free Cash Flow
-$79.68M
-$18.21M
FCF Per Share
-$2.03
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-8.21%
-21.8%
FCF Yield
-6.87%
-9.44%

Taxes and interestIndustry

Interest Expense
$2.07M
$2.90M

Scores and fair valueIndustry

Altman Z-Score
22.11
0.23
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodANROS&P 500DifferenceANRO per yearS&P 500 per year
1 month+33.7%-3.0%+36.8 pts
3 months-8.5%-2.8%−5.8 pts
Year to date+66.0%+11.5%+54.5 pts
1 year+160.3%+13.5%+146.8 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M ANRO shares were sold short on Oct 30, 2026, up 9.2% from the previous report, or 15.34% of the shares available to trade. At recent volumes it would take 10.5 days to buy them back. Over the last 20 sessions, 67.2% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20265,682,860+9.2%540,53610.5
Oct 15, 20265,204,407+11.7%694,1077.5
Sep 30, 20264,660,269+11.6%718,1876.5
Sep 15, 20264,174,082+8.8%459,4939.1
Aug 31, 20263,836,359+7.9%475,8308.1
Aug 14, 20263,556,066+9.9%475,9997.5
Jul 31, 20263,235,210+4.5%434,2657.5
Jul 15, 20263,096,805+28.5%719,8854.3
Jun 30, 20262,410,038+48.6%805,5273.0
Jun 15, 20261,622,197-4.1%373,5914.3
May 29, 20261,692,318+5.0%305,8255.5
May 15, 20261,611,876+1.6%343,5344.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?